INTRODUCTION {#sec1-1}
============

Blood volume estimation is one of the cardinal parameter necessary in cases of burns, sepsis, management of critically ill-patients undergoing major surgeries and in intensive care settings.\[[@ref1][@ref2]\] Considerable blood volume depletion or hypovolemia leads to clinically identifiable "shock," which requires emergency intervention. Smaller blood volume depletion leads to normotensive compensated shock associated with vasoconstriction of visceral organs such as gastrointestinal tract, skin, and kidneys. This diminished perfusion to the splanchnic organs results in inadequate oxygenation to the gut mucosa precipitating to a cascade of pathophysiological events proceeding to development of sepsis.\[[@ref3]\]

The existing approaches for blood volume estimations are labour intensive, intricate and time consuming. In the last many years, research has brought various methods for blood volume estimation. The widely used methods employ dye dilution and radioisotope techniques. The dye dilution technique using Evans blue dye (EBD) method has limitations due to hypersensitivity reactions in patient and tissue discoloration. The radioisotope labelling methods involving either albumin or red blood cells (RBCs) is time consuming, cumbersome and cannot be repeated on the same patient due to the prolonged stay of radioactive material in the body in the labelled form.\[[@ref4]\]

The gold standard method of blood volume estimation using radioisotopes, though accurate has complex procedures, forcing the clinicians to opt and practice on easier and less accurate methods such as history, physical examination, systemic blood pressure, central venous pressure and urine volume.\[[@ref5][@ref6][@ref7]\] It is important to note these methods do not allow for calculation of absolute blood volume. Available reports indicate inaccurate volume assessment holds many risk factors, often leading to inappropriate, unnecessary therapeutic intervention and mortal outcomes.\[[@ref8]\]

The aim of this experimental study using New Zealand white rabbit model was to compare blood volume estimation using \[^51^Cr(III)\] with that of EBD method and to establish a correction-factor (CF), which can be further related for human application.

MATERIALS AND METHODS {#sec1-2}
=====================

The study was approved by the institutional animal ethics committee. A total of 33 New Zealand white rabbits (*Oryctolagus cuniculus*), which includes 11 males and 22 females weighing approximately 1.5-3.1 kg were used in this experiment. All animals were kept on dietary restriction to stabilise fluctuations in blood volume during the experimental period. Ten minutes before the experiment, rabbits were placed in restrainer and anaesthetised with ketamine hydrochloride (25 mg/kg body weight) injection through the marginal ear vein. The site of injection and blood sample collection was prepared by shaving the area on both ear and gently wiping with 70% alcohol swab.

An intravenous (IV) cannula of 26 GA (BD Neoflon™ Singapore) was inserted to the marginal vein of one of the ear and secured it with an adhesive plaster. This was used for injection of drug or dye in to the vascular system. In to the other ear to withdraw blood a 24 GA (BD Neoflon™ Singapore) IV cannula was placed in the central auricular artery and secured with an adhesive plaster.

All animals were assigned to go through blood volume measurement using EBD method described by Armin *et al*. followed by ^51^Cr(III).\[[@ref4][@ref9]\] An initial (blank) blood sample of 3.2 ml was withdrawn from the auricular artery followed by injection of 1 ml of 0.2% EBD (Himedia Lab. Pvt. Ltd, Mumbai) solution in normal saline through the marginal vein. Subsequently, 0.5 ml saline was used to wash the injected dye. After 8 min, another 2.2 ml blood sample was withdrawn and after this at every 8 min interval three 2.2 ml blood samples were withdrawn.

All samples were collected in heparinised vacutainer and plasma separated from whole blood samples. EBD content was determined by means of a spectrophotometric assay (Thermo scientific GENESYS 10UV, USA). A volume of 1 ml plasma of each blood sample was placed in a 1 ml spectrometer cuvette and the absorbance read at 650 nm. The concentration of dye was calculated from the standard curve of EBD solution in pooled plasma of rabbits.\[[@ref10]\]

Plasma volume V, was obtained from ![](IJPS-47-242-g001.jpg)

Where; C~st~ = Dye concentration of standard (2000 μg/ml)

V = Volume of injected EBD

C~sa~ = Dye concentration of samples corrected for dye loss and for spontaneous dilution.

Correction for spontaneous dilution of the blood {#sec2-1}
------------------------------------------------

Intermittent blood withdrawal from rabbit in a brief time period often leads to slight decrease in levels of plasma proteins, which leads to alteration of plasma EBD concentration during measurements. Noble *et al*. suggested a formula for correction of fluid shift assuming that the proportion of T-1824 labelled protein to total protein remains constant during the experiment.\[[@ref11][@ref12]\]
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Where; C = Corrected concentration of the n^th^ sample of plasma with dye

C~n~ = The observed concentration of dye in the n^th^ sample

A~1~ = The total protein concentration of the 1^st^ plasma sample with dye

A~n~ = The total protein concentration of the nth dyed sample.

Determination of C~sa~ {#sec2-2}
----------------------

C~sa~ is the concentration of dye that would be found if the T-1824 were distributed without loss through circulating plasma. This concentration is required in calculating the plasma volume. Estimation of C~sa~ was done by extrapolation back to zero time.\[[@ref9]\]

Determination of haematocrit {#sec2-3}
----------------------------

Haematocrit was measured by centrifuging 100 mm columns of blood in 3 mm bore Wintrobe tube at 3000 rpm for 30 min in a centrifuge head of 15 cm radius.\[[@ref13]\] All packed cell volume measurements were multiplied by 0.95, since 5% of the packed cell volume consists of plasma.

Calculation of blood volume {#sec2-4}
---------------------------

Estimation of blood volume was calculated from measured plasma volume and haematocrit,\[[@ref14]\]
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Blood volume estimation using ^51^Cr(III) {#sec2-5}
-----------------------------------------

2 mCi of ^51^Cr in aqueous solution was obtained from Board of Radiation and Isotope Technology, DAE, GOI. Two hours prior to the estimation of blood volume using ^51^Cr(III), a syringe was loaded with ^51^Cr(III) by reducing ^51^Cr in aqueous solution with freshly prepared ascorbic acid (Sisco Research Laboratories Pvt. Ltd, Mumbai.) solution (0.2 mg/ml), which is sufficient to transform entire ^51^Cr in aqueous solution to ^51^Cr(III).\[[@ref15]\] Activity of the loaded syringe was determined in a calibrated Nucleonix Gamma Ray Spectrometer having NaI (Tl) based well type scintillation detector coupled to single channel analyser.

Approximately, 3000 counts per second (cps) of ^51^Cr(III) in 1 ml were injected initially to the animal through the IV cannula inserted to the marginal vein followed by 0.5 ml saline to wash the injected ^51^Cr(III) solution. The syringe used for injection of the dose then collected and measured for the remaining activity. The dose mentioned above is the actual dose that has gone in to the animal by subtracting the left over activity in the syringe. An electronic timer was preset for a minute before the experiment and switched on immediately following injection. After a minute, 1 ml blood sample were obtained after dilution from the central artery and its activity determined in a well type scintillation counter for 360 s.

Blood volume was obtained from the equation,
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Where; C~1~ = Concentration of tracer injected

C~2~ = Concentration of the tracer in the unknown volume

V~1~ = Volume of tracer injected

V~2~ = Unknown volume to be measured

Development of correction-factor {#sec2-6}
--------------------------------

Entire sample size (*n* = 33) were randomly divided using statistical package for social sciences (SPSS 15.0, IBM Corporation) in to two groups. The CF was calculated by dividing the estimated blood volume using EBD with blood volume estimated using radioactive ^51^Cr(III) as discussed by Modi *et al*.\[[@ref16]\] Group I, with 60% of the total sample size (*n* = 20) were used to develop CF and the mean CF obtained. Group II, with 40% of the total sample size (*n* = 13) were used for validation of CF.

Validation of the correction-factor {#sec2-7}
-----------------------------------

The CF obtained from Group I was then applied to Group II by multiplying the CF to each value obtained in Group II. After applying CF, the data were analysed for any significant difference between Group II and blood volume estimation using Evans blue method.

Statistical analysis {#sec2-8}
--------------------

Blood volume measurement using EBD and direct injection of ^51^Cr(III) were analysed using paired *t*-test and by the method of Bland and Altman plot for assessing the agreement between two methods of clinical measurement.\[[@ref17]\] All results were expressed in mean ± standard deviation (SD) and *P* \< 0.05 was considered to be statistically significant. SPSS 15.0 was used for the analysis.

RESULTS {#sec1-3}
=======

The data of 33 rabbits shows a mean body weight of 2.18 ± 0.35 kg, mean arterial packed cell volume of 35.11 ± 3.85%. The mean circulating blood volume (CVB) using EBD was 142.02 ± 22.77 ml or 65.76 ± 9.31 ml/kg. In this group, subsequent determination of the mean CVB by injection of ^51^Cr(III) was estimated to be 195.66 ± 47.30 ml with the mean CVB being 89.81 ± 17.88 ml. On an average, 53.64 ml (95% confidence interval (CI) - 39.57, 66.86 ml) is the difference in blood volume between the two methods (*P* \< 0.001).

A Bland Altman plot of blood volume obtained using EBD and direct injection of ^51^Cr(III) is shown in [Figure 1](#F1){ref-type="fig"}. The red line indicates the limits of agreement and green line indicates the mean of the two measurements. The limits of agreement were from −23.6 to 130.2 ml.

![Blood volume obtained using Evans blue dye and direct injection of ^51^Cr(III) without applying correction-factor (*n* = 33)](IJPS-47-242-g005){#F1}

Development of correction-factor {#sec2-9}
--------------------------------

Owing to the difference in the blood volume values in the two methods of blood volume estimation and a statistically significant difference therein, CF was developed. Among the 33 rabbits, 20 randomly selected rabbits (60% of total number) were used for the development of CF and the remaining 13 rabbits were used for validating the CF. The fourth column in [Table 1](#T1){ref-type="table"} gives the ratio of the both methods. The mean and SD of the ratio is 0.77 ± 0.14, which was used as the CF. The values of 20 rabbits selected for CF development is given below in [Table 1](#T1){ref-type="table"}.

###### 

Development of CF

![](IJPS-47-242-g006)

Validation of correction-factor {#sec2-10}
-------------------------------

In the validation group, mean blood volume of 13 rabbits measured using EBD was 139.54 ± 27.19 ml or 66.33 ± 8.26 ml/kg body weight. In the same group, blood volume measurement using ^51^Cr(III) without applying CF showed a mean blood volume of 199.21 ± 60.33 ml or 93.73 ± 18.01 ml/kg body weight. On an average, 59.67 ml (95% CI - 35.41, 83.94) is the difference between the two methods (*P* \< 0.001). In the same group, the mean blood volume measurement by ^51^Cr(III) with CF was 152.73 ± 46.25 ml or 71.87 ± 13.81 ml/kg body weight. The average difference is 13.19 ml (95% CI - 3.44, 29.83) between the two methods (*P* = 0.110) \[[Table 2](#T2){ref-type="table"}\].

###### 

Comparison of blood volume obtained by EBD, ^51^Cr(III) without applying CF and ^51^Cr(III) with CF
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A Bland Altman plot for blood volume obtained using EBD and direct injection of ^51^Cr(III) with CF in the validation group is shown in [Figure 2](#F2){ref-type="fig"}. The plot showed that the limits of agreement were from 68.26 to −41.86. The 95% CI for the lower limits of agreement is −70.68 to −13.04 ml and for the upper limit is 39.44-97.07 ml.

![Blood volume obtained using Evans blue dye and direct injection of ^51^Cr(III) with correction-factor (*n* = 13)](IJPS-47-242-g008){#F2}

DISCUSSION {#sec1-4}
==========

Accurate and rapid measurement of blood volume in critical care situations is a challenge for the clinicians in intensive care units. Inability to fix the volume status in hypovolemic situations increases morbidity and mortality in critically ill-patients. Although there are many techniques existing for measurement of CVB, there is dearth for a method, which is easy, reliable and repeatable in nature for use in routine clinical settings. The available methods are inherently complex and time consuming and most dye methods results in unacceptable levels of tissue discoloration and associated hypersensitivity reactions. Moreover, inaccuracies associated with radioactive labelled RBCs or albumin limits their use in blood volume measurement.\[[@ref18]\]

This study explores the possibility of using ^51^Cr(III) to overcome the shortcomings mentioned above. We compared the measurements obtained by trivalent chromium with that of EBD dilution technique. The blood volume values obtained by EBD method were comparable with the existing normal values available for New Zealand white rabbits.\[[@ref19][@ref20]\] Initial experiments in rabbits using hexavalent chromium we observed higher blood volume values owing to the fact that during mixing it is permeable through the cell membranes and uptake by various tissues is comparatively higher leading to overestimation of blood volume. Subsequently, we used ^51^Cr(III), which is not permeable through cell membranes and relatively less up taken by various tissues as established by Gray and Sterling.\[[@ref21]\] The blood volume values obtained with ^51^Cr(III) also showed significant difference with that of EBD method. This difference is attributed to the loss of ^51^Cr(III) in to the interstitial space, third space loss, excreted in urine and other body secretions. This loss of ^51^Cr(III) necessitates the development of CF.

After applying CF to blood volume value obtained by 51Cr (III) in the validation group, the two methods were comparable and the mean difference between the two groups was 13.19 ml. Among the measured blood volume values of the 13 rabbits in the validation group, value of one of the rabbits was above two SD and this may be due to an experimental error. After eliminating this value, which was above two SD, the mean difference was found to be only 6.67 ml. In 2007, in a pilot study, we used hexavalent chromium to find a simple, quick and method, which can be used in clinical settings.\[[@ref4]\] In this study with better understanding about loss of hexavalent chromium due to its ability to cross cell membranes, we selected trivalent chromium.\[[@ref21]\]

Time taken for blood volume estimation by EBD method in this study was approximately 1.7 h (average). This method is not used in human studies because of reports of tissue discoloration and suspicion of carcinogenicity.\[[@ref3]\]

The present experimental study was conducted in New Zealand white rabbits. Hence, it is not possible to compare cost with other available human studies without any extrapolation. On extrapolation of our experiment to human experiment for cost analysis, we found that total cost for one reference Indian adult will be approximately INR 1000. The time required for estimation was found to be 0.15 h, which is much less, compared to various methods quoted in the literature \[[Table 3](#T3){ref-type="table"}\].\[[@ref22]\]

###### 

Cost and time comparison with other human study

![](IJPS-47-242-g009)

CONCLUSION {#sec1-5}
==========

The method offers an alternative for existing blood volume estimation methods which is easy, quick, can be done in clinical settings and repeatable as ^51^Cr(III) is not bound to albumin or RBCs. The values obtained are comparable with the standard Evans blue method with the CF. The validity of this technique in situations where cardiac output is very low is uncertain. We need to look at the applicability of this method in acute clinical settings and there is a need to develop CF for it. To conclude estimation of blood volume using ^51^Cr(III) was comparable to standard EBD method using CF. With further research in this direction we foresee human blood volume estimation using ^51^Cr(III) to find its application in acute clinical settings.
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